Genetic Variant | Haplotype | Non-Hispanic White | Non-Hispanic Black | Mexican American | |||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
 |  | β (95% CI) | FDR-adjusted P value* | β (95% CI) | FDR-adjusted P value | β (95% CI) | FDR-adjusted P value | ||||||
Crude Analysis | |||||||||||||
High-density lipoprotein cholesterol | |||||||||||||
PON1 | A-A | -6.56 (-13.78,0.66) | 0.3814 | -0.91 (-8.16,6.35) | 0.9641 | 6.81 (2.89,10.73) | 0.0179 | ||||||
 | A-G | -7.94 (-25.71,9.83) | 0.697 | -1.45 (-9.49,6.59) | 0.9641 | 22.04 (4.73,39.34) | 0.0777 | ||||||
 | T-A | -3.75 (-7.46,-0.05) | 0.3814 | -0.12 (-5.58,5.34) | 0.9641 | 1.03 (-3.09,5.14) | 0.8002 | ||||||
 | T-G | REF |  | REF |  | REF |  | ||||||
Low-density lipoprotein cholesterol | |||||||||||||
APOE | C-C | 12.12 (-4.40,28.64) | 0.2499 | 4.92 (-5.58,15.41) | 0.9016 | 15.43 (5.73,25.14) | 0.0494 | ||||||
 | T-C | REF |  | REF |  | REF |  | ||||||
 | T-T | -30.86 (-56.47,-5.25) | 0.1066 | -40.25 (-57.28,-23.22) | 0.001 | -38.64 (-67.23,-10.05) | 0.0721 | ||||||
NOS3 | C-G | -6.17 (-19.32,6.98) | 0.4971 | 2.26 (-15.53,20.05) | 0.9861 | -0.62 (-10.80,9.56) | 0.9665 | ||||||
 | C-T | 3.85 (-11.06,18.76) | 0.7161 | 38.05 (4.28,71.81) | 0.1927 | 0.24 (-11.33,11.80) | 0.9665 | ||||||
 | T-G | REF |  | REF |  | REF |  | ||||||
 | T-T | 0.82 (-23.44,25.08) | 0.9704 | 2.94 (-11.50,17.37) | 0.9861 | -20.78 (-34.52,-7.03) | 0.0494 | ||||||
PON1 | A-A | 10.91 (-0.74,22.56) | 0.1706 | 4.89 (-12.82,22.60) | 0.9861 | 2.45 (-9.04,13.94) | 0.8789 | ||||||
 | A-G | 46.49 (21.16,71.82) | 0.0063 | 8.91 (-12.85,30.68) | 0.9016 | 6.44 (-25.95,38.84) | 0.8789 | ||||||
 | T-A | 8.98 (-2.58,20.53) | 0.247 | -1.09 (-11.58,9.40) | 0.9861 | -2.04 (-8.21,4.13) | 0.8789 | ||||||
 | T-G | REF |  | REF |  | REF |  | ||||||
Total serum cholesterol | |||||||||||||
APOE | C-C | 14.28 (-2.27,30.82) | 0.2221 | 6.28 (-4.99,17.54) | 0.7536 | 15.21 (2.29,28.14) | 0.3143 | ||||||
 | T-C | REF |  | REF |  | REF |  | ||||||
 | T-T | -24.87 (-51.22,1.48) | 0.2172 | -31.33 (-50.53,-12.13) | 0.052 | -19.40 (-38.15,-0.64) | 0.3143 | ||||||
Adjusted Analysis** | |||||||||||||
High-density lipoprotein cholesterol | |||||||||||||
PON1 | A-A | -4.86 (-11.20,1.48) | 0.4856 | -1.92 (-9.08,5.24) | 0.8857 | 6.14 (3.44,8.84) | 0.0021 | ||||||
 | A-G | -5.79 (-14.56,2.98) | 0.4856 | 2.17 (-5.89,10.24) | 0.8857 | 19.62 (6.84,32.39) | 0.0441 | ||||||
 | T-A | -3.22 (-6.60,0.17) | 0.4856 | 1.52 (-4.67,7.71) | 0.8857 | 1.23 (-2.73,5.20) | 0.7102 | ||||||
 | T-G | REF |  | REF |  | REF |  | ||||||
Low-density lipoprotein cholesterol | |||||||||||||
APOE | C-C | 12.93 (-3.41,29.26) | 0.3459 | 4.01 (-8.26,16.28) | 0.8555 | 21.28 (13.93,28.64) | <.0001 | ||||||
 | T-C | REF |  | REF |  | REF |  | ||||||
 | T-T | -31.14 (-56.65,-5.64) | 0.0992 | -44.33 (-59.39,-29.27) | <.0001 | -43.23 (-64.13,-22.34) | 0.0016 | ||||||
NOS3 | C-G | -3.42 (-15.49,8.65) | 0.676 | 2.68 (-13.71,19.06) | 0.8555 | -3.05 (-8.55,2.46) | 0.6162 | ||||||
 | C-T | 6.48 (-10.27,23.22) | 0.6032 | 31.18 (4.64,57.72) | 0.233 | -0.69 (-10.02,8.64) | 0.9344 | ||||||
 | T-G | REF |  | REF |  | REF |  | ||||||
 | T-T | 1.64 (-20.75,24.03) | 0.8806 | 1.95 (-10.32,14.21) | 0.8555 | -32.14 (-47.72,-16.55) | 0.0016 | ||||||
PON1 | A-A | 8.77 (-5.24,22.77) | 0.4865 | 8.10 (-9.66,25.85) | 0.8555 | -2.54 (-15.41,10.32) | 0.8479 | ||||||
 | A-G | 40.03 (19.65,60.41) | 0.0053 | 10.90 (-12.43,34.24) | 0.8555 | 9.62 (-21.64,40.88) | 0.7428 | ||||||
 | T-A | 9.78 (-0.77,20.33) | 0.2366 | -2.95 (-13.93,8.03) | 0.8555 | -3.33 (-12.53,5.87) | 0.7428 | ||||||
 | T-G | REF |  | REF |  | REF |  | ||||||
Total serum cholesterol | |||||||||||||
APOE | C-C | 16.52 (0.51,32.53) | 0.153 | 5.32 (-8.35,18.99) | 0.8062 | 22.41 (14.73,30.10) | <.0001 | ||||||
 | T-C | REF |  | REF |  | REF |  | ||||||
 | T-T | -27.18 (-52.46,-1.90) | 0.153 | -40.42 (-57.41,-23.43) | 0.002 | -25.23 (-39.80,-10.66) | 0.0119 |